$1.18
0.19.26%
At Close: -
$1.15
-0.03-2.54%
After Hours: 7:52 PM EDT
15 minutes delayed
Comments
Loading...
CARISMA Therapeutics (NASDAQ:CARM) Stock, Earnings Estimates, EPS, And Revenue
CARISMA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-0.300
Quarterly Revenue Estimate
$3.9M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$15.1M
Analyze the earnings history of CARISMA Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CARM | CARISMA Therapeutics | -$0.49 | -$0.30 | — | — | $3.56M | $3.92M | — | — | 08/08/2024 | Get Alert |
| CARM | CARISMA Therapeutics | -$1.93 | -$0.43 | -$0.46 | -6.98% | $3.24M | $4.40M | $3.40M | -22.80% | 05/09/2024 | Get Alert |
| CARM | CARISMA Therapeutics | — | -$0.55 | -$0.52 | 5.45% | — | $2.90M | $4.29M | 47.90% | 04/01/2024 | Get Alert |
| CARM | CARISMA Therapeutics | -$8.37 | -$0.57 | -$0.53 | 7.02% | $2.58M | $1.20M | $3.83M | 218.92% | 11/09/2023 | Get Alert |
| CARM | CARISMA Therapeutics | -$7.20 | -$0.60 | -$0.49 | 18.33% | $2.70M | $1.07M | $3.56M | 232.71% | 08/10/2023 | Get Alert |
| CARM | CARISMA Therapeutics | -$5.49 | -$0.89 | -$1.93 | -116.85% | $822.00K | $3.73M | $3.24M | -13.06% | 05/11/2023 | Get Alert |
CARISMA Therapeutics (CARM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.46 | $-0.43 | -6.98 % |
| Mar 2024 | 2024-04-01 | $-0.52 | $-0.55 | 5.45 % |
| Sep 2023 | 2023-11-09 | $-0.53 | $-0.57 | 7.02 % |
| Jun 2023 | 2023-08-10 | $-0.49 | $-0.60 | 18.3 % |
CARISMA Therapeutics (CARM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $3.40M | $4.40M | -22.8 % |
| Mar 2024 | 2024-04-01 | $4.29M | $2.90M | 47.9 % |
| Sep 2023 | 2023-11-09 | $3.83M | $1.20M | 218.9 % |
| Jun 2023 | 2023-08-10 | $3.56M | $1.07M | 232.7 % |
FAQ
When is CARISMA Therapeutics (NASDAQ:CARM) reporting earnings?
CARISMA Therapeutics (CARM) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for CARISMA Therapeutics (NASDAQ:CARM)?
The Actual EPS was $-0.46, which missed the estimate of $-0.43.
What were CARISMA Therapeutics’s (NASDAQ:CARM) revenues?
The Actual Revenue was $3.4M, which missed the estimate of $4.4M.
Browse earnings estimates, EPS, and revenue on all stocks.